Rilmenidine promotes MTOR-independent autophagy in the mutant SOD1 mouse model of amyotrophic lateral sclerosis without slowing disease progression

Nirma D. Perera, Rebecca K. Sheean, Chew L. Lau, Yea Seul Shin, Philip M. Beart, Malcolm Horne, Bradley J. Turner

Autophagy · 2017 · 89 citations · 48 references

DOIFull text

Open access

Concepts

Abstract

mice. These effects were associated with increased accumulation and aggregation of insoluble and misfolded SOD1 species outside the autophagy pathway, and severe mitochondrial depletion in motor neurons of rilmenidine-treated mice. These findings suggest that rilmenidine treatment may drive disease progression and neurodegeneration in this mouse model due to excessive mitophagy, implying that alternative strategies to beneficially stimulate autophagy are warranted in ALS.

References

48